Business Description
TruScreen Group Limited is a New Zealand-based medical device company focused on the early detection of cervical cancer. Its core product is the TruScreen device, which identifies precancerous and cancerous tissue on the cervix instantly, without the need for laboratory testing. The company operates across several international markets, including China, Russia, Mexico, Vietnam, Zimbabwe, and parts of the Middle East and North Africa.
